MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Science  26 Apr 2007:

DOI: 10.1126/science.1141478

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview

Cited By...